Glenmark Pharmaceuticals is planning to list its generics subsidiary — Glenmark Generics — and has filed a draft red herring prospectus with SEBI.

Vivimed Labs Limited (VLL), a manufacturer of speciality chemicals and pharmaceuticals, has embarked on a Rs 130-crore expansion plan to be executed over the next three years. The Bidar-based company with corporate headquarters in Hyderabad is setting up two greenfield plants at Visakhapatnam and Hyderabad.

Fast moving consumer goods (FMCG) company Dabur is planning to acquire more companies in the healthcare segment in India and could spend up to Rs 500 crore for the buyouts. The move follows the recent acquisition of Fem Care Pharma for over Rs 250 crore.

The US authorities still need to bless the settlement that Sun Pharma has entered into with Forest Laboratories Holdings (FRX) over the patent litigation for Lexapro,an anti-depressant. However, the Street cheered the move and the stock was up 2 per cent in an otherwise weak market.